Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Prazole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109970705A details copper-catalyzed Ullmann coupling for high-purity epipiprazole intermediate, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel preparation method controls water content below 0.03%. Enhances oxidation selectivity and yield for esomeprazole manufacturing.
Patent CN115368317A details a novel salting-out method for 1-(2,3-dichlorophenyl)piperazine hydrochloride, ensuring low dimer impurities and reduced solvent usage.
Patent CN1634889A details a novel synthesis for Aripiprazole intermediates using low-toxicity solvents and improved efficiency for reliable API supply chains.
Patent CN101417910A details solid acid catalysis for prazole nitration, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN104829588A offers high-yield benzo[b]thiophene intermediate synthesis. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.
Patent CN113354623A reveals a novel thiourea dioxide reduction route for ilaprazole intermediates, offering superior purity and cost efficiency for API manufacturing.